Razvan Olivian Betea

Dr. Razvan Olivian Betea


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
RBRazvan Olivian Betea
Razvan Olivian Betea
CBCamelia Budisan
Camelia Budisan
LSLivia Claudia Stanga
Livia Claudia Stanga
Maria Cezara MuresanMaria Cezara Muresan
Maria Cezara Muresan
ZPZoran Popa
Zoran Popa
VCVeronica Daniela Chiriac
Veronica Daniela Chiriac
Background and Objectives: Uterine cancer is the most common gynaecologic malignancy in developed countries, yet the psychosocial sequelae of treatment are incompletely described. This prospective, single-centre study quantified six-month changes in the quality of life (QoL) and perceived stress in women with newly diagnosed uterine cancer and explored clinical moderators of change. Methods: Participants completed four validated self-report questionnaires: the 36-item Short-Form Health Survey (SF-36), the 26-item World Health Organization Quality-of-Life-BREF (WHOQOL-BREF), the 30-item EORTC QLQ-C30 and the 10-item Perceived Stress Scale (PSS-10) before therapy and again six months after surgery ± adjuvant chemoradiation. Subgroup analyses were performed for stage (FIGO I–II vs. III–IV). Results: Mean SF-36 Physical Functioning improved from 58.7 ± 12.1 to 63.1 ± 12.6 (Δ = +4.4 ± 7.3; p = 0.000, d = 0.36). PSS declined from 24.1 ± 5.6 to 20.8 ± 5.4 (Δ = −3.3 ± 5.0; p < 0.001, d = 0.66). The WHOQOL-BREF Physical and Psychological domains rose by 4.4 ± 6.9 and 3.5 ± 7.3 points, respectively (both p < 0.01). EORTC QLQ-C30 Global Health increased 5.1 ± 7.6 points (p < 0.001) with parallel reductions in fatigue (−5.4 ± 9.0) and pain (−4.8 ± 8.6). Advanced-stage patients showed larger reductions in stress (ΔPSS −3.5 ± 2.5 vs. −2.3 ± 2.3; p = 0.036) but similar QoL gains. ΔPSS correlated inversely with ΔWHOQOL Psychological (r = −0.53) and ΔSF-36 Mental Health (r = −0.49) and positively with ΔEORTC Global Health (r = −0.42) (all p < 0.001). Conclusions: Over six months, multimodal uterine cancer treatment was associated with clinically meaningful QoL improvements and moderate stress reduction. Greater stress relief paralleled superior gains in psychological and global health indices, highlighting the importance of integrative survivorship care.

25 February 2025 in Diseases
Verified
Journal Article
Open access
PDF file
RBRazvan Olivian Betea
Razvan Olivian Betea
DMDima Mirabela
Dima Mirabela
VCVeronica Daniela Chiriac
Veronica Daniela Chiriac
Background and Objectives: Cervical cancer places substantial burdens on physical and psychosocial health. This study evaluated changes in quality of life (QoL) and perceived stress in patients with cervical cancer before and six months after initiating standard treatment. Four validated instruments were used: the 36-Item Short Form Survey (SF-36), the Perceived Stress Scale (PSS), the World Health Organization Quality of Life-BREF (WHOQOL-BREF), and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Methods: Ninety-six women (mean age: 48.3 ± 7.4 years) with histologically confirmed cervical cancer were enrolled. Baseline (pre-treatment) assessments included SF-36, PSS, WHOQOL-BREF, and EORTC QLQ-C30. Follow-up was conducted six months after initiating either surgery or chemoradiation. Paired t-tests (or Wilcoxon signed-rank for non-parametric data) compared baseline and follow-up scores. Subgroup analyses were performed by disease stage (early vs. advanced) and marital status (married vs. unmarried). Results: Post-treatment assessments showed significant improvements in SF-36 physical functioning (from 61.9 ± 11.6 to 66.7 ± 12.3, p = 0.015) and mental health (from 63.4 ± 12.2 to 68.1 ± 12.4, p = 0.022). PSS scores declined from 23.2 ± 5.7 to 20.6 ± 5.5 (p = 0.001). WHOQOL-BREF physical and psychological domains increased, with physical health rising from 56.4 ± 12.0 to 60.7 ± 12.5 (p = 0.032). EORTC QLQ-C30 global health improved from 61.4 ± 13.8 to 66.3 ± 14.2 (p = 0.014). Advanced-stage patients exhibited greater absolute QoL gains yet remained below the early-stage scores. Married patients reported sharper reductions in PSS and higher final QoL scores. Conclusions: Over six months of standard cervical cancer treatment, these patients demonstrated significant QoL improvements and reduced perceived stress. While advanced-stage disease remained associated with lower post-treatment scores, these individuals benefited from notable gains compared to baseline. Marital status emerged as a protective factor. Ongoing psychosocial support may amplify these beneficial effects, warranting further longitudinal studies to optimize integrative survivorship care.

10 April 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
GSGeanina Sacarin
Geanina Sacarin
Ahmed Abu-AwwadAhmed Abu-Awwad
Ahmed Abu-Awwad
RNRazvan Nitu
Razvan Nitu
MCMarius L. Craina
Marius L. Craina
MPMihaela Prodan
Mihaela Prodan
AAAlina Simona Abu-Awwad
Alina Simona Abu-Awwad
Background: This prospective comparative study investigates urinary incontinence (UI), often associated with grade 2 cystocele, a condition that poses significant physical, emotional, and social challenges for affected women. While anterior colporrhaphy remains the gold standard for anatomical correction, non-invasive alternatives such as EMSella therapy have gained increasing attention. The study compares the outcomes of these two distinct approaches in managing UI and the associated pelvic organ prolapse. Materials and Methods: This study involved 133 menopausal women with grade 2 cystocele and UI, including 78 treated with anterior colporrhaphy and 55 with EMSella therapy, across two Romanian healthcare centers. Outcomes were assessed through prolapse reduction (POP-Q), bladder function normalization, recurrence rates, quality of life (PFDI-20, PFIQ-7), patient satisfaction, complication rates, recovery times, and social or professional disruptions. Results: Anterior colporrhaphy was more effective in anatomical correction (88% vs. 64% achieving stage 0 prolapse) and bladder function normalization (72% vs. 55%, p = 0.04), with lower one-year recurrence rates (14% vs. 31%, p = 0.03). EMSella therapy allowed faster recovery, with 91% resuming daily activities within a week. Both groups showed improvement in quality of life, but reductions in PFDI-20 and PFIQ-7 scores were more significant after surgery. EMSella had fewer infections and no dyspareunia, reflecting a better safety profile. Conclusions: EMSella therapy and anterior colporrhaphy significantly benefit managing UI associated with grade 2 cystocele. While anterior colporrhaphy provides definitive anatomical correction and superior long-term outcomes, EMSella therapy represents a safer, less invasive alternative with rapid recovery, making it ideal for patients with mild conditions or surgical contraindications. Treatment should be tailored to individual patient needs and preferences.

Verified
Journal Article
Open access
PDF file
CBCamelia Budisan
Camelia Budisan
RBRazvan Olivian Betea
Razvan Olivian Betea
Maria Cezara MuresanMaria Cezara Muresan
Maria Cezara Muresan
ZPZoran Popa
Zoran Popa
CCCosmin Ioan Citu
Cosmin Ioan Citu
VCVeronica Daniela Chiriac
Veronica Daniela Chiriac
Background and Objectives: Epithelial ovarian cancer (EOC) remains the deadliest gynecologic malignancy, yet the psychosocial dynamics of early survivorship are inadequately described. We prospectively quantified six-month trajectories in the quality of life in a consecutive cohort of 88 women newly diagnosed with EOC and explored clinical moderators of change. Methods: Eighty-eight consecutive patients (mean age 59.1 ± 10.7 years) completed the SF-36, WHOQOL-BREF, EORTC QLQ-C30, and 10-item Perceived Stress Scale (PSS-10) at baseline (pre-therapy) and six months after cytoreductive surgery ± platinum-based chemotherapy. Stage (FIGO I–II vs. III–IV) and treatment pathway (primary debulking surgery, neoadjuvant chemotherapy plus interval debulking, chemotherapy only) data were recorded. Results: Global QoL improved significantly (EORTC Global Health +5.9 ± 7.7 points; p < 0.001) while perceived stress declined (ΔPSS −3.6 ± 5.1; p < 0.001). SF-36 Physical Functioning rose 4.7 ± 7.9 points (p < 0.001) and Mental Health 4.4 ± 7.9 points (p = 0.004). The WHOQOL Physical and Psychological domains gained 4.7 ± 7.1 and 4.3 ± 7.4 points, respectively (both p < 0.01). Advanced-stage patients experienced larger stress reductions than early-stage patients (−4.1 ± 2.7 vs. −2.9 ± 2.2; p = 0.028) but comparable QoL gains. Greater stress relief correlated with greater mental-health improvement (r = −0.51) and global-health gains (r = −0.45) (all p < 0.001). Treatment pathway did not significantly influence trajectories. Conclusions: Early survivorship after first-line ovarian-cancer therapy was characterized by the clinically meaningful recovery of physical and emotional functioning together with the moderate alleviation of perceived stress. Improvements were observed irrespective of stage and treatment strategy, suggesting that contemporary multimodal regimens do not inevitably compromise patient-reported outcomes. Our estimates provide preliminary effect sizes that should be validated in multi-center cohorts with longer follow-up.

6 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Maria Cezara MuresanMaria Cezara Muresan
Maria Cezara Muresan
MBMarius Biris
Marius Biris
Răzvan RoșcaRăzvan Roșca
Răzvan Roșca
PAPescaru Andrei
Pescaru Andrei
CCCosmin Ioan Citu
Cosmin Ioan Citu
VBVictor Bogdan Buciu
Victor Bogdan Buciu
Background/Objectives: Perioperative red blood cell (RBC) transfusion after cesarean delivery reflects both obstetric hemorrhagic risk and the capacity of the care environment. We evaluated whether out-of-hours cesarean delivery was independently associated with transfusion in a Romanian tertiary maternity unit operating under constrained resources. Methods: We conducted a retrospective unmatched case–control study of cesarean deliveries performed from 2023 to 2025. All eligible transfused women were included as cases; two non-transfused controls per case were randomly selected within each calendar year. Eligibility required preoperative hemoglobin ≥ 10 g/dL and normal coagulation. The primary exposure was out-of-hours surgery, and multivariable logistic regression adjusted for maternal, obstetric, placental, and hematological factors. Results: The source population contained 6773 cesarean deliveries, with 608 transfusions (9.0%). The analytical sample comprised 401 cases and 802 controls. Out-of-hours procedures occurred in 64.1% of cases and 52.5% of controls (crude OR 1.62, 95% CI 1.26–2.07). After adjustment, out-of-hours delivery remained associated with transfusion (aOR 2.03, 95% CI 1.45–2.84). Placenta previa, suspected placenta accreta spectrum, and lower preoperative hemoglobin were the strongest clinical predictors. When postoperative/pre-transfusion hemoglobin was added, the out-of-hours association attenuated to an aOR of 1.02 (95% CI 0.63–1.65); sensitivity analyses remained consistent with the primary model. Conclusions: Out-of-hours cesarean delivery was associated with approximately two-fold higher transfusion odds after adjustment for the measured clinical factors. Because cesarean indication, urgency, and labor characteristics were not available, this association may partly reflect the different case mix and acuity of out-of-hours surgery rather than the working period itself. Attenuation after adjustment for post-exposure hemoglobin is compatible with, but does not establish greater perioperative blood loss. In high-cesarean, resource-constrained settings, standardized hemorrhage-risk identification and equivalent preparedness across duty periods warrant prospective evaluation in studies that also record indication and urgency.